Join us April 10 as we announce the $200K Challenge Winners!

Join us on April 10 as we announce the winner of the 7th annual M2D2 $200K Challenge!More than 100 entrants from around the world. Nineteen finalists. And awards worth a total of $200,000.

It’ll all come together at the Boston offices of Mintz Levin this Tuesday evening, April 10, at the Award Ceremony and Networking Event for the 7th Annual M2D2 $200K ChallengeEveryone in the greater Boston medical technology and life sciences communities is welcome to attend.  Continue reading

Meet an M2D2 $200K Finalist: Nolen Ortho

Nolen Ortho is a finalist in the 7th Annual M2D2 $200K Challenge.

Darren Nolen of Nolen Ortho

Nolen Ortho is one of 20  medtech  startups chosen as finalists in the 7th annual M2D2 $200K Challenge.  Founder/Inventor Darren Nolen tells the story of his innovation’s journey from inspiration to the Challenge finals.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

Nolen Ortho develops next-generation tissue repair materials using our controlled activation technology: bone glue, osteoporosis repair, spinal fusion. Continue reading

Meet an M2D2 $200K Challenger: Fairbanks Pharmaceuticals

Fairbanks Pharmaceuticals is a finalist in the 7th annual M2D2 $200K Challenge.

Alan Schneyer of Fairbanks Pharmaceuticals

Introducing Fairbanks Pharmaceuticals, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. CEO Alan Schneyer explains their innovation and shares the story of its development.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

Fairbanks Pharmaceuticals is developing a novel treatment for type 1 and type 2 diabetes that addresses the underlying cause of the disease. Continue reading

Meet an M2D2 $200K Challenge Finalist: Integrated Medical Sensors

Integrated Medical Sensors is a finalist in the 7th annual M2D2 $200K Challenge.

Muhammad Mujeeb- U-Rahman of Integrated Medical Sensors

Integrated Medical Sensors is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. CEO Muhammad Mujeeb-U-Rahman recounts the journey of their innovation from inspiration to development to the Challenge finals.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

IMS has developed the world’s smallest wireless glucose sensor that requires no calibration, is user-insertable, and works for 30 days or longer.  Continue reading

Meet an M2D2 $200K Finalist: Advanced Silicon Group

Advanced Silicon Group is a finalist in the 7th Annual M2D2 $200K Challenge.

ASG co-founders Marcie Black and Bill Rever

Advanced Silicon Group (ASG) is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. CEO Marcie Black told us the story behind their innovation and shared their vision for its future. 

What is the innovation you’ve entered in the M2D2 $200K Challenge?

ASG is enabling drug developers to measure the concentration of biomarkers in patients’ blood, giving an early indicator in clinical trials. Continue reading

Meet an M2D2 $200K Challenge Finalist: Versatope

Versatope is a finalist in the 7th Annual M2D2 $200K Challenge

Clockwise from top left: Christopher Locher, CEO/Co-Founder; Mark Duffy, CFO/COO; Kien Nguyen, Senior Director, Microbiology; David Putnam, Co-Founder; Matthew DeLisa, Co-Founder; Ly Phan, SVP, Portfolio Management & Preclinical Development

Meet Versatopeone of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. SVP Ly Phan described their innovation and shared the story behind its inspiration and development.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

An immuno-therapeutic and vaccine delivery platform made from probiotic exosomes (extracellular vesicles)—designed by nature and customized by Versatope to deliver immunity. Continue reading

Meet an M2D2 $200K Finalist: MedKairos

MedKairos is a finalist in the 7th annual M2D2 $200K Challenge.

Andy Kozminski and Michael Moore of MedKairos

MedKairos is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder Michael Moore explained their innovation and the story behind its inspiration and development.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

One out of five biopsies fails to return a diagnosis. Our technology intervenes during the procedure, so patients will only undergo the procedure once. Continue reading